Skip to main content
. 2017 Oct;8(3):e148–e156. doi: 10.2500/ar.2017.8.0216

Figure 1.

Figure 1.

Effect of MP-AzeFlu (Dymista®) on the visual analog scale (VAS) score over time in (A) the total population (n = 160) and (B) according to baseline severity. Less severe, baseline VAS score of 50–74 mm; more severe, baseline VAS score of 75–100 mm. Data are presented as mean ± standard deviation. **The mean of the last day corresponds to day 16.2.